Article | February 23, 2020

Automating Cell Therapy Systems For Better Results

Source: Cytiva
Investigating Growth In Clinical Trials Part 2: Growth By Therapeutic Area

Today’s cell therapy treatments are often made at a small-scale, include manual preparation, and are usually produced for use in a clinical trial. Researchers spend days processing cellular material, monitoring its growth during the expansion phase, and preparing it for re-administration to the patient. With autologous treatments, this process must be completed for every patient to create their unique living drug.

In return, cell therapy offers life-changing outcomes. For example, terminal acute lymphoblastic leukemia patients achieved complete remission in 90% of cases during one cell therapy trial. But what if it were possible to get those results on a much broader scale? Automation may hold the key to making this happen.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: